Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • FDI in India rises to...

    FDI in India rises to 61.96 billion dollar in 2017-18: Government

    Written by Ruby Khatun Khatun Published On 2018-06-10T10:00:23+05:30  |  Updated On 10 Jun 2018 10:00 AM IST
    FDI in India rises to 61.96 billion dollar in 2017-18: Government

    New Delhi: Foreign direct investment (FDI) in India increased by about 3 percent to $61.96 billion in 2017-18 on account of steps taken by the government to improve the business climate and liberalized policy norms.


    FDI inflows stood at $60 billion in the previous fiscal. The figure includes equity inflows, reinvested earnings and other capital.


    Department of Industrial Policy and Promotion (DIPP) Secretary Ramesh Abhishek said that during the four years of the Modi government, foreign inflows jumped to $222.75 billion from $152 billion in the previous four-year period.


    In the last four years, the government has liberalized FDI norms in sectors such as defence, medical devices, construction development, retail and civil aviation. The main sectors that received maximum foreign inflows include services, computer software, and hardware, telecommunications, construction, trading, and automobile.


    Major sources of foreign inflows include Mauritius, Singapore, Japan, the Netherlands, the US, Germany, France and the UAE.


    However, according to a UNCTAD report yesterday, foreign direct investment (FDI) to India decreased to $40 billion in 2017 from $44 billion in 2016, while outflows from India, the main source of investment in South Asia, more than doubled.


    Foreign inflows are crucial for India, which needs huge investments to overhaul its infrastructure such as ports, airports, and highways to push growth. It helps improve the country's balance of payments situation and strengthen the rupee value against other global currencies, especially the US dollar.


    Speaking on FDI issues, Commerce and Industry Minister Suresh Prabhu said that the government abolished foreign investment promotion board to facilitate overseas investments.


    Most of the sectors are under automatic approval route for FDI purposes, he said.


    When asked about the issue of iPhone maker Apple and US-based electric car major Tesla, he said India would welcome investments from all companies, including these two.


    "We are awaiting a formal proposal from them and then we will look into it," he said.


    The Cupertino-based iPhone and iPad manufacturer Apple have asked for certain concessions for setting up the manufacturing unit in the country.


    "We will be very happy to receive a proposal" from Tesla also, he added.


    US-based electric vehicle maker Tesla recently cited a challenging environment for not making it to the Indian market.

    Applebusiness climateCommerce and Industry MinisterdefenceDepartment of Industrial Policy and PromotionDIPPFDIforeign direct investmentgovernmentiPadiPhoneliberalized policy normsMedical DevicesModiRamesh AbhishekSuresh Prabhu
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok